Relmacabtagene Autoleucel Injection (CXSS2000036) Application for Technical Review Report for Market Authorization

Relmacabtagene Autoleucel Injection (CXSS2000036) is a biological product used to treat relapsed or refractory large B cell lymphoma in adult patients after two or more lines of systemic therapy.

File format
PDF
Published
29 October, 2023
Updated
29 October, 2023
MD5 checksum
ABC323AB07A3F562A2DE1A8F66EB5CC0
PDF
Relmacabtagene Autoleucel Injection (CXSS2000036) Application for Technical Review Report for Market Authorization PDF
Download PDF

Also Manuals

ManualLib.com

ManualLib.com is a comprehensive platform that offers an extensive collection of instruction manuals for a diverse range of products from around the globe. Our mission is to provide users with easy access to these manuals at all times and from any location, enabling them to make the most out of their purchases and improve their user experience.